title: Possible involvement of PPAR-γ in the anticonvulsant effect of Aegle marmelos (L.) Correa.
abstract: Aegle marmelos is well documented for antihyperglycemic effect and PPAR-γ activation has been suggested to be the molecular mechanism of its action. Also, the plant has been used in Ayurveda as a brain tonic and has been postulated to have antidepressant activities. The present study was designed to investigate the anticonvulsant effects of A. marmelos leaf extract (AME) in pentylenetetrazole and maximal electroshock induced convulsions; involvement of PPAR-γ, nitric oxide pathway and effect of chronic AME treatment on post-ictal depression. AME was administered at doses of 50, 100 and 200 mg kg(-1) in PTZ and MES model. Severity of convulsions was noted in both the models. Pretreatment with bisphenol A diglycidyl ether (BADGE) was used to study the involvement of PPAR-γ and L-arginine and N-nitro-L-arginine methyl ester hydrochloride (L-NAME) to study the involvement of nitric oxide (NO). Chronic treatment with AME interspersed with sub maximal doses of PTZ (50 mg kg(-1)) on every fifth day up to 15 days was given to study post-ictal depression using forced swimming and actophotometer. AME showed significant increase in the onset time and decrease in the duration of convulsions in PTZ and MES models dose dependently. In MES a dose of 100 mg kg(-1) had effect comparable to phenytoin. Pretreatment with BADGE and L-arginine reversed the protective effect while L-NAME did not alter the protective effect, thereby indicating possible involvement of PPAR-γ and inhibition of NO. Chronic AME treatment ameliorated the post-seizure depression significantly as evidenced by increase in the locomotor activity and decrease in the immobility time.
authors: Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, India. rbhatti75@gmail.com
authors: Rajbir
authors: R
authors: Bhatti
authors: Jatinder
authors: J
authors: Singh
authors: Kunal
authors: K
authors: Nepali
authors: M P S
authors: MP
authors: Ishar
mesh_terms: D045471:Aegle / Q000737:chemistry*; D000927:Anticonvulsants / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D047495:PPAR gamma / Q000502:physiology*
chemical_list: D000927:Anticonvulsants; D047495:PPAR gamma
references: Epilepsy Res. 2012 Aug;101(1-2):28-35
references: 22436324
references: J Neurosci. 2000 Sep 15;20(18):6862-7
references: 10995830
references: Ann Neurol. 1995 Feb;37(2):146-57
references: 7847856
references: Curr Neuropharmacol. 2012 Dec;10(4):328-43
references: 23730257
references: Endocrinology. 1996 Jan;137(1):354-66
references: 8536636
references: Biochim Biophys Acta. 2007 Aug;1771(8):1031-45
references: 17569578
references: J Neurochem. 2002 Aug;82(3):615-24
references: 12153485
references: J Ethnopharmacol. 2012 Jan 6;139(1):273-9
references: 22107833
references: Indian J Exp Biol. 1993 Apr;31(4):345-7
references: 8359833
references: Biofactors. 1998;8(1-2):33-40
references: 9699006
references: J Neuroimmunol. 1999 Dec;100(1-2):156-68
references: 10695726
references: Lancet Neurol. 2012 Sep;11(9):792-802
references: 22832500
references: Phytomedicine. 2006 Jun;13(6):434-41
references: 16716914
references: J Neurosci Res. 2003 Feb 1;71(3):315-25
references: 12526021
references: Epilepsy Res. 2009 Aug;85(2-3):293-9
references: 19406619
references: J Ethnobiol Ethnomed. 2012 Apr 04;8:14
references: 22472473
references: Phytother Res. 2011 Oct;25(10):1457-65
references: 21351301
references: Pharmacol Rev. 1991 Jun;43(2):109-42
references: 1852778
references: J Ethnopharmacol. 2009 Jun 22;123(2):330-4
references: 19429380
references: Science. 1991 Jun 28;252(5014):1788
references: 1712121
references: Neuroscience. 2004;123(1):131-45
references: 14667448
references: Neuroscience. 2004;129(3):757-66
references: 15541897
references: Epilepsy Behav. 2011 Aug;21(4):356-63
references: 21723789
references: Indian J Physiol Pharmacol. 2010 Oct-Dec;54(4):318-28
references: 21675029
references: Pharmacol Rev. 2006 Dec;58(4):726-41
references: 17132851